Subject(s)
COVID-19 , Early Detection of Cancer/statistics & numerical data , Prostate-Specific Antigen/blood , Prostatic Neoplasms/diagnosis , Aged , Australia , Biopsy/statistics & numerical data , Hematologic Tests/statistics & numerical data , Humans , Male , Middle Aged , Multiparametric Magnetic Resonance Imaging/statistics & numerical data , Prostate/pathology , Prostatectomy/statistics & numerical data , Prostatic Neoplasms/blood , Prostatic Neoplasms/pathology , Prostatic Neoplasms/surgery , SARS-CoV-2Subject(s)
Biopsy/statistics & numerical data , Inpatients/statistics & numerical data , Referral and Consultation/trends , Skin/pathology , Telemedicine/instrumentation , Biopsy/methods , COVID-19/diagnosis , COVID-19/epidemiology , COVID-19/pathology , COVID-19/virology , Curriculum/trends , Dermatology/education , Dermatology/methods , Diagnosis, Differential , Female , Humans , Internship and Residency/statistics & numerical data , Male , Pathology/education , Pathology/methods , Quality Improvement , Retrospective Studies , SARS-CoV-2/genetics , Surveys and Questionnaires , User-Computer InterfaceSubject(s)
2019-nCoV Vaccine mRNA-1273 , BNT162 Vaccine , COVID-19 , Chemical and Drug Induced Liver Injury , Risk Adjustment/methods , 2019-nCoV Vaccine mRNA-1273/administration & dosage , 2019-nCoV Vaccine mRNA-1273/adverse effects , BNT162 Vaccine/administration & dosage , BNT162 Vaccine/adverse effects , Biopsy/methods , Biopsy/statistics & numerical data , COVID-19/epidemiology , COVID-19/prevention & control , COVID-19 Vaccines/administration & dosage , COVID-19 Vaccines/adverse effects , Chemical and Drug Induced Liver Injury/blood , Chemical and Drug Induced Liver Injury/diagnosis , Chemical and Drug Induced Liver Injury/epidemiology , Chemical and Drug Induced Liver Injury/prevention & control , Cholangiopancreatography, Endoscopic Retrograde/methods , Cholangiopancreatography, Endoscopic Retrograde/statistics & numerical data , Cohort Studies , Female , Humans , Liver Function Tests/methods , Male , Middle Aged , Pharmacovigilance , SARS-CoV-2 , Time FactorsSubject(s)
COVID-19/prevention & control , Cancer Care Facilities/organization & administration , Dermatologic Surgical Procedures , Medical Oncology/organization & administration , Pandemics , SARS-CoV-2 , Skin Neoplasms/surgery , Age Distribution , Biopsy/statistics & numerical data , COVID-19/diagnosis , COVID-19/epidemiology , COVID-19 Testing , Comorbidity , Cross Infection/prevention & control , Dermatologic Surgical Procedures/statistics & numerical data , Humans , Medical Oncology/methods , Postoperative Complications/epidemiology , Procedures and Techniques Utilization , Skin Neoplasms/pathology , Symptom AssessmentABSTRACT
Aim: To describe the activity in the 'breast unit' at the department of radiology during the COVID-19 lockdown in a university hospital treating COVID-19 patients in a Middle-Eastern developing country. Materials: This was a retrospective study conducted from March 9 until 11 May 2020, in the breast unit at the department of radiology of a central university hospital in a Middle-Eastern developing country. Data were collected from 205 patients visiting the breast unit during the lockdown period and compared with the activity in the same period in the previous year. Results: Reduction of the breast unit activity was estimated at 73%. In addition, 153 mammograms, 205 ultrasounds, and 16 breast MRIs were done. Indications for mammogram were screening (41.5%), follow-up (22%), clinical symptoms (20%) and breast cancer surveillance (16.5%). MRI was performed mostly for preoperative surgical management. The rate of positive biopsies was 41%. All staff members and patients have accommodated to new adjustments. Conclusion: Activity in the breast unit dropped during the lockdown period. Staff should continue to seek their own and their patient's safety without diminishing the quality of healthcare.
Subject(s)
Biopsy/statistics & numerical data , Magnetic Resonance Imaging/statistics & numerical data , Mammography/statistics & numerical data , Mass Screening/statistics & numerical data , Radiology Department, Hospital/statistics & numerical data , Adolescent , Adult , Aged , Aged, 80 and over , Breast Neoplasms/diagnosis , Breast Neoplasms/diagnostic imaging , COVID-19/epidemiology , Female , Humans , Lebanon/epidemiology , Middle Aged , Quality of Health Care , Retrospective Studies , SARS-CoV-2 , Young AdultABSTRACT
The coronavirus disease 2019 (COVID-19) pandemic during the first months of 2020 is causing profound changes in worldwide health care systems, resulting in a major reduction of surgical interventions and routine non-urgent outpatient diagnostic procedures. The lockdown due to the COVID-19 pandemic in Italy, one of the most affected countries in Europe, is having severe effects on the otolaryngology medical and surgical activities. The main changes are represented by the postponement of outpatient visits and scheduled surgery, while the only guaranteed service is reserved to diagnostics and surgery for oncology and urgent patients. In these cases, given the sites of action typical of the otolaryngology practice, physicians and nurses are exposed to a high risk of contagion through virus aerosol transmission. Furthermore, as the current measures of lockdown continue, it will be difficult to perform scheduled and new diagnostic assessments, medical treatments and surgical procedures in a timely manner favoring the risk of diagnostic and therapeutic delays with severe impact on patients' health.